Mannosylated neutrophil vesicles targeting macrophages alleviate liver inflammation by delivering CRISPR/Cas9 RNPs
Theranostics · 2025
DOI: 10.7150/thno.107791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Dongqing Wu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei 230000, Anhui, China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Macrophages, Neutrophils, Ribonucleoproteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Inflammation is a key driver of various liver diseases. NLRP3 inflammasome in hepatic macrophages is a key mediator of inflammation and has emerged as a promising target. Genome editing presents a powerful approach to modulate inflammation by directly disrupting genes such as NLRP3 directly. However, efficient and cell-specific delivery of CRISPR/Cas9 ribonucleoproteins (RNPs) remains challenging.
Methods
We developed a novel delivery system by encapsulating CRISPR/Cas9 RNPs within mannosylated neutrophil membranes vesicles (Cas9/gNLRP3@M-N) to enhance targeting hepatic macrophages.
Results
Cas9/gNLRP3@M-N selectively accumulated in hepatic macrophages, effectively disrupted the NLRP3 gene, attenuated inflammation in acute fulminant hepatitis, and improved disease outcomes in chronic steatohepatitis model.
Conclusions
Cas9/gNLRP3@M-N represents a promising targeted gene-editing approach for the treatment of inflammatory liver diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei 230000, Anhui, China.
- School of Pharmaceutical Sciences, Anhui Medical University, Hefei 230032, China.
- Innovation and Entrepreneurship Laboratory for College Students, Anhui Medical University, Hefei 230000, Anhui, China.
- Department of Gastroenterology, the First Affiliated Hospital of Anhui Medical University, Hefei 230000, Anhui, China.
- School of Basic Medical Science, Anhui Medical University, Hefei 230000, Anhui, China.
- School of Life Sciences, Anhui Medical University, Hefei 230000, Anhui, China.
Zitieren
APA
Wu, D., Shu, H., Zhang, M., Wei, X., Ji, J., Shen, H., Zhang, H., Xie, L., Zhou, L., Yang, L., Jiang, J., Chen, C., Tian, S., Zhang, X., Long, X., He, X., & Wang, H. (2025). Mannosylated neutrophil vesicles targeting macrophages alleviate liver inflammation by delivering CRISPR/Cas9 RNPs. Theranostics. https://doi.org/10.7150/thno.107791
Vancouver
Wu D, Shu H, Zhang M, Wei X, Ji J, Shen H, et al. Mannosylated neutrophil vesicles targeting macrophages alleviate liver inflammation by delivering CRISPR/Cas9 RNPs. Theranostics. 2025. doi:10.7150/thno.107791
BibTeX
@article{Wu2025,
author = {Wu, Dongqing and Shu, Hang and Zhang, Mengmeng and Wei, Xiaoli and Ji, Jingjing and Shen, Haiyuan and Zhang, Hejiao and Xie, Linxi and Zhou, Liangliang and Yang, Lei and Jiang, Jiali and Chen, Chen and Tian, Shanfei and Zhang, Xinru and Long, Xu and He, Xiaoyan and Wang, Hua},
title = {Mannosylated neutrophil vesicles targeting macrophages alleviate liver inflammation by delivering CRISPR/Cas9 RNPs},
journal = {Theranostics},
year = {2025},
doi = {10.7150/thno.107791}
}
EUVIMED